The past three years for Ligand Pharmaceuticals (NASDAQ:LGND) investors has not...

Published on 20 Jun 2024 on Simply Wall St. · via Yahoo Finance

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) shareholders should be happy to see the share...

Read the rest of the article

Start tracking your investments with Statfolio

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) shareholders should be happy to see the share...

Simply Wall St. · via Yahoo Finance 20 Jun 2024

Editas Medicine, Inc. EDIT incurred a loss of 76 cents per share in the first quarter of 2024, wi...

Zacks via Yahoo Finance 9 May 2024

Halozyme Therapeutics, Inc. HALO reported first-quarter 2024 adjusted earnings of 79 cents per sh...

Zacks via Yahoo Finance 8 May 2024

Ligand Pharmaceuticals Incorporated LGND reported core adjusted diluted net income per share of $...

Zacks via Yahoo Finance 8 May 2024

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript May 7, 2024 Li...

Insider Monkey via Yahoo Finance 8 May 2024

Axsome Therapeutics, Inc. AXSM reported an adjusted loss of $1.00 per share for the first quarter...

Zacks via Yahoo Finance 8 May 2024

Roche RHHBY announced that the FDA has approved a label expansion of its lung cancer drug, Alecen...

Zacks via Yahoo Finance 19 Apr 2024

Vanda Pharmaceuticals Inc. VNDA announced that its board of directors has unanimously rejected a ...

Zacks via Yahoo Finance 18 Apr 2024

Neumora Therapeutics, Inc. NMRA announced that the FDA has placed a clinical hold on the phase I ...

Zacks via Yahoo Finance 16 Apr 2024

Corcept Therapeutics Incorporated CORT announced that it has completed enrollment in the phase II...

Zacks via Yahoo Finance 16 Apr 2024